These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
289 related articles for article (PubMed ID: 33835423)
21. PKM2 functions as a histidine kinase to phosphorylate PGAM1 and increase glycolysis shunts in cancer. Wang Y; Shu H; Qu Y; Jin X; Liu J; Peng W; Wang L; Hao M; Xia M; Zhao Z; Dong K; Di Y; Tian M; Hao F; Xia C; Zhang W; Ba X; Feng Y; Wei M EMBO J; 2024 Jun; 43(12):2368-2396. PubMed ID: 38750259 [TBL] [Abstract][Full Text] [Related]
22. PKM2 methylation by CARM1 activates aerobic glycolysis to promote tumorigenesis. Liu F; Ma F; Wang Y; Hao L; Zeng H; Jia C; Wang Y; Liu P; Ong IM; Li B; Chen G; Jiang J; Gong S; Li L; Xu W Nat Cell Biol; 2017 Nov; 19(11):1358-1370. PubMed ID: 29058718 [TBL] [Abstract][Full Text] [Related]
23. The Role of PKM2 in Metabolic Reprogramming: Insights into the Regulatory Roles of Non-Coding RNAs. Puckett DL; Alquraishi M; Chowanadisai W; Bettaieb A Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33503959 [TBL] [Abstract][Full Text] [Related]
24. Allosteric regulation of PKM2 allows cellular adaptation to different physiological states. Gui DY; Lewis CA; Vander Heiden MG Sci Signal; 2013 Feb; 6(263):pe7. PubMed ID: 23423437 [TBL] [Abstract][Full Text] [Related]
25. FOXM1D potentiates PKM2-mediated tumor glycolysis and angiogenesis. Zhang W; Zhang X; Huang S; Chen J; Ding P; Wang Q; Li L; Lv X; Li L; Zhang P; Zhou D; Wen W; Wang Y; Lei QY; Wu J; Hu W Mol Oncol; 2021 May; 15(5):1466-1485. PubMed ID: 33314660 [TBL] [Abstract][Full Text] [Related]
26. Pyruvate kinase isoform M2 (PKM2) participates in multiple myeloma cell proliferation, adhesion and chemoresistance. He Y; Wang Y; Liu H; Xu X; He S; Tang J; Huang Y; Miao X; Wu Y; Wang Q; Cheng C Leuk Res; 2015 Dec; 39(12):1428-36. PubMed ID: 26453405 [TBL] [Abstract][Full Text] [Related]
27. HDAC8-dependent deacetylation of PKM2 directs nuclear localization and glycolysis to promote proliferation in hepatocellular carcinoma. Zhang R; Shen M; Wu C; Chen Y; Lu J; Li J; Zhao L; Meng H; Zhou X; Huang G; Zhao X; Liu J Cell Death Dis; 2020 Dec; 11(12):1036. PubMed ID: 33279948 [TBL] [Abstract][Full Text] [Related]
28. PKM2 Modulation in Head and Neck Squamous Cell Carcinoma. Boschert V; Teusch J; Müller-Richter UDA; Brands RC; Hartmann S Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054968 [TBL] [Abstract][Full Text] [Related]
29. Tumor treating fields (TTFields) impairs aberrant glycolysis in glioblastoma as evaluated by [ Patel CB; Beinat C; Xie Y; Chang E; Gambhir SS Neoplasia; 2021 Jan; 23(1):58-67. PubMed ID: 33221711 [TBL] [Abstract][Full Text] [Related]
30. Emerging roles of PKM2 in cell metabolism and cancer progression. Luo W; Semenza GL Trends Endocrinol Metab; 2012 Nov; 23(11):560-6. PubMed ID: 22824010 [TBL] [Abstract][Full Text] [Related]
31. Expression and clinical significance of pyruvate kinase M2 in breast cancer: A protocol for meta-analysis and bioinformatics validation analysis. Li H; Yan M; Wu X; Wang Y; Huang L Medicine (Baltimore); 2021 May; 100(18):e25545. PubMed ID: 33950928 [TBL] [Abstract][Full Text] [Related]
32. Activators of PKM2 in cancer metabolism. Warner SL; Carpenter KJ; Bearss DJ Future Med Chem; 2014 Jun; 6(10):1167-78. PubMed ID: 25078136 [TBL] [Abstract][Full Text] [Related]
33. HSP90 promotes cell glycolysis, proliferation and inhibits apoptosis by regulating PKM2 abundance via Thr-328 phosphorylation in hepatocellular carcinoma. Xu Q; Tu J; Dou C; Zhang J; Yang L; Liu X; Lei K; Liu Z; Wang Y; Li L; Bao H; Wang J; Tu K Mol Cancer; 2017 Dec; 16(1):178. PubMed ID: 29262861 [TBL] [Abstract][Full Text] [Related]
34. CHIP/Stub1 regulates the Warburg effect by promoting degradation of PKM2 in ovarian carcinoma. Shang Y; He J; Wang Y; Feng Q; Zhang Y; Guo J; Li J; Li S; Wang Y; Yan G; Ren F; Shi Y; Xu J; Zeps N; Zhai Y; He D; Chang Z Oncogene; 2017 Jul; 36(29):4191-4200. PubMed ID: 28346425 [TBL] [Abstract][Full Text] [Related]
35. HSP40 interacts with pyruvate kinase M2 and regulates glycolysis and cell proliferation in tumor cells. Huang L; Yu Z; Zhang T; Zhao X; Huang G PLoS One; 2014; 9(3):e92949. PubMed ID: 24658033 [TBL] [Abstract][Full Text] [Related]
36. Structural insight into mechanisms for dynamic regulation of PKM2. Wang P; Sun C; Zhu T; Xu Y Protein Cell; 2015 Apr; 6(4):275-287. PubMed ID: 25645022 [TBL] [Abstract][Full Text] [Related]
37. Pyruvate kinase M2: A multifarious enzyme in non-canonical localization to promote cancer progression. Amin S; Yang P; Li Z Biochim Biophys Acta Rev Cancer; 2019 Apr; 1871(2):331-341. PubMed ID: 30826427 [TBL] [Abstract][Full Text] [Related]
38. PKM2, cancer metabolism, and the road ahead. Dayton TL; Jacks T; Vander Heiden MG EMBO Rep; 2016 Dec; 17(12):1721-1730. PubMed ID: 27856534 [TBL] [Abstract][Full Text] [Related]
39. Proviral insertion in murine lymphomas 2 (PIM2) oncogene phosphorylates pyruvate kinase M2 (PKM2) and promotes glycolysis in cancer cells. Yu Z; Zhao X; Huang L; Zhang T; Yang F; Xie L; Song S; Miao P; Zhao L; Sun X; Liu J; Huang G J Biol Chem; 2013 Dec; 288(49):35406-16. PubMed ID: 24142698 [TBL] [Abstract][Full Text] [Related]
40. LncCCAT1 interaction protein PKM2 upregulates SREBP2 phosphorylation to promote osteosarcoma tumorigenesis by enhancing the Warburg effect and lipogenesis. Pu F; Liu J; Jing D; Chen F; Huang X; Shi D; Wu W; Lin H; Zhao L; Zhang Z; Lv X; Wang B; Zhang Z; Shao Z Int J Oncol; 2022 Apr; 60(4):. PubMed ID: 35244192 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]